Ro.co vs Telos Rx: Oral Wegovy vs Compounded GLP-1 Options
Ro.co vs Telos Rx answers whether you prefer an FDA-approved oral GLP-1 or lower-cost compounded options. Early verdict: choose Ro.co if you prioritize access to the Wegovy pill and branded, FDA-evaluated finished medication; choose Telos Rx if you prioritize lower starting monthly pricing with compounded semaglutide or tirzepatide, subject to clinician approval and compounded-medication limitations.
Key differences at a glance: Ro.co vs Telos Rx
This comparison uses only captured evidence. The most distinctive differences are medication form and regulatory status, starting price and ongoing cost framing, medication choices available, and how each platform frames clinician review and eligibility.
Distinctive differences compared directly
| Criteria | Ro.co | Telos Rx |
|---|---|---|
| Medication type | Wegovy pill, FDA-approved oral GLP-1; not compounded | Compounded semaglutide & tirzepatide (GLP-1 and GLP-1 + GIP) |
| Regulatory note | FDA-approved finished medication; compounded medications are not FDA-approved | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
| Starting price | Get Started Online for Just $39 | As low as $99 per month (semaglutide); tirzepatide as low as $139 per month |
| Medication options | Branded oral semaglutide (Wegovy pill) and other FDA-approved meds | Semaglutide and tirzepatide compounded (provider decides which is right) |
| Clinical approval | Treatment available only when a licensed clinician determines it is medically appropriate | Prescribed only after review by a US-licensed provider; subject to medical approval |
Medication form and regulatory status
Ro.co is the only mainstream platform in this comparison with access to the Wegovy pill, described as the first and only FDA-approved oral GLP-1 weight loss medication on the captured page. The source emphasizes that Ro offers FDA-approved finished medication rather than compounded products. Telos Rx prescribes compounded semaglutide and tirzepatide and explicitly states that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. These regulatory distinctions are central when comparing Ro.co vs Telos Rx.
Price entry point and ongoing cost framing
Ro.co highlights “Get Started Online for Just $39” as an entry point, while noting branded medications like the Wegovy pill carry higher ongoing costs. Telos Rx lists compounded semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” and presents per-month pricing subject to provider approval. Both sources say treatment is available only after clinician review; Ro.co emphasizes no hidden fees and disclosed pricing before completing consultation, while Telos Rx cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
See Telos Rx pricing and options
Medication choice and clinical matching
Ro.co focuses on providing the branded oral option, framed as meaningful for injection-averse patients. Telos Rx offers two compounded molecules: semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP), noting a US-licensed provider decides which molecule is right. Telos Rx frames tirzepatide as dual-action versus semaglutide as the original GLP-1 pathway.
Transparency, limitations, and best-fit patients
Ro.co positions itself as an established full-service telehealth platform with disclosed pricing and regulatory assurance because it prescribes FDA-approved finished products. The captured evidence lists Ro.co’s cons: branded medications can cost significantly more than compounded alternatives. Telos Rx directs readers to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment and warns pricing and terms may change. Both platforms require clinician review and medical appropriateness.
Get started with Ro.co weight care
Final comparison and how to choose: Ro.co vs Telos Rx
In short, Ro.co offers the FDA-approved Wegovy pill and a $39 online start, trading higher ongoing branded medication costs for FDA-reviewed finished medication. Telos Rx offers lower advertised monthly entry pricing for compounded semaglutide and tirzepatide (as low as $99 and $139 per month) but emphasizes compounded medications are not FDA-approved and that eligibility and pricing are subject to clinician approval and change.
Explore Telos Rx treatment options
Choose Ro.co if…
you want access to the Wegovy pill, prefer an FDA-approved oral GLP-1 finished medication rather than a compounded product, value pricing disclosure before consultation, and are willing to accept higher branded medication costs.
Choose Telos Rx if…
you prioritize lower starting monthly pricing for compounded semaglutide or tirzepatide, understand compounded medications are not FDA-approved, and will confirm eligibility, pharmacy, state coverage and renewal terms before enrolling.